(Q31130554)

29 June 2017

1 reference

title

Therapeutic studies in hepatic encephalopathy (English)

1 reference

29 June 2017

main subject

hepatic encephalopathy

1 reference

Kevin D Mullen

1

1 reference

29 June 2017

Piero Amodio

series ordinal

2

1 reference

29 June 2017

Marsha Y Morgan

series ordinal

3

1 reference

29 June 2017

publication date

1 December 2007

1 reference

29 June 2017

published in

Metabolic Brain Disease

1 reference

29 June 2017

volume

22

1 reference

29 June 2017

issue

3-4

1 reference

29 June 2017

page(s)

407-423

1 reference

Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy

29 June 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11011-007-9061-6

Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11011-007-9061-6

Mini-asterixis in hepatic encephalopathy induced by pathologic thalamo-motor-cortical coupling.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11011-007-9061-6

A randomized controlled trial of acarbose in hepatic encephalopathy

21 January 2018

1 reference

12 December 2020

The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis.

1 reference

12 December 2020

Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy

1 reference

12 December 2020

Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests

1 reference

12 December 2020

Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial

1 reference

12 December 2020

Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

1 reference

12 December 2020

Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis

1 reference

12 December 2020

Attention deficits in minimal hepatic encephalopathy.

1 reference

12 December 2020

Neuropsychological aspects of portal-systemic encephalopathy

1 reference

12 December 2020

Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy

1 reference

12 December 2020

Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study

1 reference

12 December 2020

Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment

1 reference

12 December 2020

Characteristics of minimal hepatic encephalopathy

1 reference

12 December 2020

Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy.

1 reference

12 December 2020

Attention, memory, and cognitive function in hepatic encephalopathy

1 reference

12 December 2020

Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study

1 reference

12 December 2020

Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy

1 reference

12 December 2020

Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study

1 reference

12 December 2020

Visual attention in cirrhotic patients: a study on covert visual attention orienting

1 reference

12 December 2020

Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy.

1 reference

12 December 2020

Neuropsychological abnormalities in cirrhosis include learning impairment.

1 reference

12 December 2020

Spectral versus visual EEG analysis in mild hepatic encephalopathy

1 reference

12 December 2020

Neomycin in the treatment of hepatic coma

1 reference

12 December 2020

Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics

1 reference

12 December 2020

Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium

1 reference

12 December 2020

Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil

1 reference

12 December 2020

Abnormalities of the Bereitschaftspotential and MRI pallidal signal in non-encephalopathic cirrhotic patients

1 reference

12 December 2020

[Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial]

1 reference

12 December 2020

Neuropsychological characterization of hepatic encephalopathy

1 reference

12 December 2020

Changes in brain size in hepatic encephalopathy: a coregistered MRI study

1 reference

12 December 2020

Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy

1 reference

12 December 2020

Neurophysiological assessment of early hepatic encephalopathy

1 reference

12 December 2020

Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis.

1 reference

12 December 2020

Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis.

1 reference

12 December 2020

Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis

1 reference

12 December 2020

Electroencephalographic staging of hepatic encephalopathy by an artificial neural network and an expert system.

1 reference

12 December 2020

Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis.

1 reference

12 December 2020

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.

1 reference

12 December 2020

Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography

1 reference

12 December 2020

Magnetization transfer contrast of various regions of the brain in liver cirrhosis

1 reference

12 December 2020

Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy

1 reference

12 December 2020

Selecting outcome parameters in studies aimed at improving rational use of antibiotics - practical considerations

1 reference

12 December 2020

Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients

1 reference

12 December 2020

Reliability of the Columbia scale for assessing signs of Parkinson's disease

1 reference

12 December 2020

Memory function in early hepatic encephalopathy.

1 reference

12 December 2020

Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiation

1 reference

12 December 2020

The electroencephalograph in liver disease

1 reference

12 December 2020

The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation.

1 reference

12 December 2020

Minimal hepatic encephalopathy impairs fitness to drive.

1 reference

12 December 2020

Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: a behavioral and electrophysiological study

1 reference

12 December 2020

1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy.

1 reference

12 December 2020

Is acarbose an effective drug for treating patients with cirrhosis and hepatic encephalopathy?

1 reference

12 December 2020

Prognostic significance of hepatic encephalopathy in patients with cirrhosis

1 reference

12 December 2020

Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis

1 reference

12 December 2020

Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial

1 reference

12 December 2020

Treatment of the Pruritus of Cholestasis

1 reference

12 December 2020

10.1007/S11011-007-9061-6

Identifiers

DOI

1 reference

Dimensions Publication ID

29 June 2017

1047798321

0 references

1 reference